RDVT.NASDAQRed Violet, INC

Form 4: Red Violet CFO Daniel MacLachlan Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Daniel MacLachlan, CFO of Red Violet, Inc., reports the vesting and disposition of restricted stock units (RSUs) and a new grant of RSUs.

Summary

  • On November 1, 2024, Daniel MacLachlan vested 13,333 restricted stock units (RSUs) and disposed of 6,667 shares to cover tax obligations at a price of $30.08 per share.
  • Following these transactions, MacLachlan directly owns 378,084 shares of common stock.
  • On November 4, 2024, MacLachlan received a grant of 31,500 RSUs.
  • MacLachlan also indirectly owns 466 shares held by an IRA.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions. The increased ownership could be seen as slightly positive, but the tax-related sale is slightly negative.

Positives

  • The CFO's increased holdings of RSUs and common stock could be interpreted as a positive sign of confidence in the company's future performance.

Negatives

  • The disposition of shares to cover tax obligations could be seen as a minor negative, although it's a common practice.

Risks

  • The vesting of RSUs and potential future sale of shares could create downward pressure on the stock price.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs suggest continued employment and potential future increases in ownership.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Monitoring these filings can offer insights into management's sentiment and potential future stock performance.

Comparison to Industry Standards

  • Stock ownership and RSU grants are common forms of compensation for executives in publicly traded companies.
  • The size and vesting schedules of the RSU grants appear typical for a CFO role in a company of Red Violet's size and stage.

Stakeholder Impact

  • Shareholders may be interested in the CFO's stock transactions as an indicator of management's confidence.
  • The vesting of RSUs could potentially dilute existing shareholders if the shares are issued from treasury.

Key Dates

DateDescription
October 12, 2022Date of original grant approval by the Company's Compensation Committee for 13,333 restricted stock units (RSUs).
November 30, 2023Date of original grant for 40,000 RSUs.
November 1, 2024Vesting of 13,333 restricted stock units (RSUs) and disposition of 6,667 shares for tax obligations.
November 4, 2024Grant of 31,500 RSUs.
November 1, 2025Vesting date for a portion of the RSUs granted on November 4, 2024.
December 1, 2025Vesting date for a portion of the RSUs granted on November 30, 2023.
November 1, 2026Vesting date for a portion of the RSUs granted on November 4, 2024.
December 1, 2026Vesting date for a portion of the RSUs granted on November 30, 2023.
November 1, 2027Vesting date for a portion of the RSUs granted on November 4, 2024.
November 5, 2024Date of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.